Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eisuke Mekada

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
The Journal of Biological Chemistry|March 4, 2003
The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascadesHisanori Takenobu, Ayano Yamazaki, Michinari Hirata, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|August 20, 2002
CD9 expression in solid non-neuroepithelial tumors and infiltrative astrocytic tumorsMasatou Kawashima, Katsumi Doh-ura, Eisuke Mekada, et al.
Molecular Biology of the Cell|July 23, 2002
Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signalingXiaochun Yu, Kailash D Sharma, Tsuyoshi Takahashi, et al.
Journal of Biochemistry|November 30, 2014
Identification of diphtheria toxin R domain mutants with enhanced inhibitory activity against HB-EGFKeisuke Suzuki, Hiroto Mizushima, Hiroyuki Abe, et al.
Development (Cambridge, England)|June 10, 2010
HB-EGF function in cardiac valve development requires interaction with heparan sulfate proteoglycansRyo Iwamoto, Naoki Mine, Taichiro Kawaguchi, et al.
Cancer Research|July 1, 2010
Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factorNaohiko Koshikawa, Hiroto Mizushima, Tomoko Minegishi, et al.
Journal of Biochemistry|March 25, 2010
Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin bindingMiki Hamaoka, Ichino Chinen, Takuya Murata, et al.
Journal of Biochemistry|May 26, 2007
Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activityTakuya Kageyama, Minako Ohishi, Shingo Miyamoto, et al.
International Journal of Cancer|December 3, 2008
Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancerHiroshi Yagi, Fusanori Yotsumoto, Kenzo Sonoda, et al.
Plos Genetics|October 3, 2012
Tetraspanin is required for generation of reactive oxygen species by the dual oxidase system in Caenorhabditis elegansHiroki Moribe, Ryouji Konakawa, Daisuke Koga, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|March 4, 2003
The stress- and inflammatory cytokine-induced ectodomain shedding of heparin-binding epidermal growth factor-like growth factor is mediated by p38 MAPK, distinct from the 12-O-tetradecanoylphorbol-13-acetate- and lysophosphatidic acid-induced signaling cascadesHisanori Takenobu, Ayano Yamazaki, Michinari Hirata, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|August 20, 2002
CD9 expression in solid non-neuroepithelial tumors and infiltrative astrocytic tumorsMasatou Kawashima, Katsumi Doh-ura, Eisuke Mekada, et al.
Molecular Biology of the Cell|July 23, 2002
Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signalingXiaochun Yu, Kailash D Sharma, Tsuyoshi Takahashi, et al.
Journal of Biochemistry|November 30, 2014
Identification of diphtheria toxin R domain mutants with enhanced inhibitory activity against HB-EGFKeisuke Suzuki, Hiroto Mizushima, Hiroyuki Abe, et al.
Development (Cambridge, England)|June 10, 2010
HB-EGF function in cardiac valve development requires interaction with heparan sulfate proteoglycansRyo Iwamoto, Naoki Mine, Taichiro Kawaguchi, et al.
Cancer Research|July 1, 2010
Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factorNaohiko Koshikawa, Hiroto Mizushima, Tomoko Minegishi, et al.
Journal of Biochemistry|March 25, 2010
Anti-human HB-EGF monoclonal antibodies inhibiting ectodomain shedding of HB-EGF and diphtheria toxin bindingMiki Hamaoka, Ichino Chinen, Takuya Murata, et al.
Journal of Biochemistry|May 26, 2007
Diphtheria toxin mutant CRM197 possesses weak EF2-ADP-ribosyl activity that potentiates its anti-tumorigenic activityTakuya Kageyama, Minako Ohishi, Shingo Miyamoto, et al.
International Journal of Cancer|December 3, 2008
Synergistic anti-tumor effect of paclitaxel with CRM197, an inhibitor of HB-EGF, in ovarian cancerHiroshi Yagi, Fusanori Yotsumoto, Kenzo Sonoda, et al.
Plos Genetics|October 3, 2012
Tetraspanin is required for generation of reactive oxygen species by the dual oxidase system in Caenorhabditis elegansHiroki Moribe, Ryouji Konakawa, Daisuke Koga, et al.
Pageof 7